At present, immunotherapy in urological malignancy is experiencing a renaissance, particularly with the emergence of a host of innovative cancer vaccines. Herein, we will review promising immunotherapeutic approaches and evaluate the data supporting their inclusion in novel combination strategies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1442-2042.2010.02664.x | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!